The most attractive stocks to buy are often the companies you already own.
Over the past six months, CTS’s shares (currently trading at $41.45) have posted a disappointing 10.9% loss while the S&P 500 was down 1.2%. This was partly due to its softer quarterly results and might have investors contemplating their next move.
What a brutal six months it’s been for onsemi. The stock has dropped 39.3% and now trades at $42.72, rattling many shareholders. This was partly driven by its softer quarterly results and might have investors contemplating their next move.
Wrapping up Q4 earnings, we look at the numbers and key takeaways for the agricultural machinery stocks, including Titan International (NYSE:TWI) and its peers.
Since March 2020, the S&P 500 has delivered a total return of 132%. But one standout stock has more than doubled the market - over the past five years, Barrett has surged 311% to $40.13 per share. Its momentum hasn’t stopped as it’s also gained 9.1% in the last six months thanks to its solid quarterly results, beating the S&P by 10.4%.
Although the S&P 500 is down 1.2% over the past six months, CarMax’s stock price has fallen further to $70.45, losing shareholders 10.9% of their capital. This might have investors contemplating their next move.
Wrapping up Q4 earnings, we look at the numbers and key takeaways for the healthcare technology for providers stocks, including Phreesia (NYSE:PHR) and its peers.
As the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results from Q4. Today, we are looking at branded pharmaceuticals stocks, starting with Supernus Pharmaceuticals (NASDAQ:SUPN).
Looking back on toys and electronics stocks’ Q4 earnings, we examine this quarter’s best and worst performers, including Bark (NYSE:BARK) and its peers.
The Oracle of Omaha's long-term optimism and unwavering focus on value are at odds.